Year 2017 / Volume 109 / Number 9
Original
Cost-effectiveness of a hepatitis B virus screening strategy to prevent reactivation in patients with hematologic neoplasms

619-626

DOI: 10.17235/reed.2017.4693/2016

Javier Crespo, Rafael Esteban, Covadonga Torres, Itziar Oyagüez, Miguel Ángel Casado, María Buti,

Abstract
Introduction: The effectiveness of a screening strategy for the detection of a hepatitis B virus (HBV) infection followed by prophylaxis in order to prevent HBV reactivation was assessed in patients with hematologic neoplasms. Material and methods: A decision tree was developed to compare the cost and effectiveness (prevented reactivations) over an 18 month period of a screening strategy prior to chemotherapy with R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone) with a non-screening approach. HBsAg+ (hepatitis B surface antigen) and/or anti-HBc+ (antibodies to hepatitis B core antigen) and HBV-DNA+ patients received oral antiviral prophylaxis with tenofovir disoproxil (245 mg once daily) from chemotherapy baseline until one year after chemotherapy completion. Non-screened patients received tenofovir in case of a reactivation. Model probabilities were obtained from the literature. The total cost (€, 2015) included: antiviral prophylaxis, R-CHOP, screening tests (HBsAg, anti-HBc, HBV-DNA) and liver function tests. Drug therapy costs were estimated using ex-factory prices with mandatory deductions. The incremental cost-effectiveness ratio (ICER) was calculated in order to assess the cost-effectiveness of this intervention in terms of cost per reactivation averted versus no screening. Results: In a hypothetical cohort of 1,000 patients, screening prevented 7.36 reactivations when compared to the non-screening approach (14.9 versus 22.3). Total cost/patient (including €8,282 for R-CHOP) was €8,584 for the screening strategy and €8,449 for the non-screening approach. The ICER for screening versus non-screening was €18,376/prevented reactivation. Conclusion: HBV screening followed by oral antiviral prophylaxis yielded more health benefits than non-screening, reducing HBV reactivation in patients with hematologic neoplasms on chemotherapy.
Share Button
New comment
Comments
No comments for this article
Related articles

Letter

Hepatitis B virus reactivation after ibrutinib treatment

DOI: 10.17235/reed.2023.9587/2023

Letter

Histiocytic sarcoma of the esophagus

DOI: 10.17235/reed.2022.9296/2022

Digestive Diseases Image

Metastatic lesion of a choroidal melanoma located in the head of pancreas

DOI: 10.17235/reed.2022.8843/2022

Letter

Pancreatic lipoma: diagnostic boom of a rare mesenchymal tumor

DOI: 10.17235/reed.2022.8536/2021

Letter

Brunneroma: an infrequent duodenal neoplasm

DOI: 10.17235/reed.2021.8349/2021

Letter

Gruber-Frantz tumor: a rare pancreatic neoplasm

DOI: 10.17235/reed.2021.8345/2021

Digestive Diseases Image

Malignancy of intraductal papillary neoplasm of the bile duct

DOI: 10.17235/reed.2021.8193/2021

Letter

Primary Ewing's sarcoma of the small intestine

DOI: 10.17235/reed.2021.7735/2020

Editorial

Screening guide for hepatitis C virus infection in Spain

DOI: 10.17235/reed.2020.7728/2020

Digestive Diseases Image

Inflammatory pseudotumor-like follicular dendritic cell sarcoma of the liver

DOI: 10.17235/reed.2020.7602/2020

Original

Can we optimize CEA as a response marker in rectal cancer?

DOI: 10.17235/reed.2020.7321/2020

Review

New non-invasive biomarkers for colorectal cancer screening

DOI: 10.17235/reed.2020.7233/2020

Special Article

Strategy for the Elimination of Hepatitis C in Cantabria

DOI: 10.17235/reed.2020.7108/2020

Editorial

Colorectal endoscopic submucosal dissection is here to stay

DOI: 10.17235/reed.2020.6960/2020

Letter

Medullary colorectal carcinoma. Do we really know it?

DOI: 10.17235/reed.2020.6728/2019

Editorial

Safe surgery for cystic tumors of the pancreas

DOI: 10.17235/reed.2019.6042/2018

Editorial

Colorectal cancer screening and survival

DOI: 10.17235/reed.2018.5870/2018

Letter

Why anal cytology is not enough in a dysplasia screening program

DOI: 10.17235/reed.2018.5678/2018

Letter to the Editor

Sternal cutaneous metastasis of hilar cholangiocarcinoma

DOI: 10.17235/reed.2017.4979/2017

Letter to the Editor

Sister Mary Joseph’s nodule as initial pancreatic cancer manifestation

DOI: 10.17235/reed.2016.4479/2016

Case Report

Hemobilia due to intracholecystic papillary neoplasm

DOI: 10.17235/reed.2016.4205/2016

Case Report

Mesenteric schwannoma: an unusual cause of abdominal mass

DOI: 10.17235/reed.2016.4202/2016

Letter to the Editor

Surgical management of appendiceal adenocarcinoid. Case report and literature review

DOI: 10.17235/reed.2016.4049/2015

Letter to the Editor

Mucinous hepatic cystic neoplasm: An uncommon cystic lesion in the liver

DOI: 10.17235/reed.2015.3698/2015

Letter to the Editor

Leiomyoma of the round ligament of the liver: Report of one case

DOI: 10.17235/reed.2015.3725/2014

Citation tools
Crespo J, Esteban R, Torres C, Oyagüez I, Casado M, Buti M, et all. Cost-effectiveness of a hepatitis B virus screening strategy to prevent reactivation in patients with hematologic neoplasms . 4693/2016


Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Metrics
This article has received 231 visits.
This article has been downloaded 222 times.

Statistics from Dimensions


Statistics from Plum Analytics

Publication history

Received: 25/10/2016

Accepted: 11/04/2017

Online First: 26/06/2017

Published: 31/08/2017

Article revision time: 164 days

Article Online First time: 244 days

Article editing time: 310 days


Share
This article hasn't been rated yet.
Reader rating:
Valora este artículo:




Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
The Spanish Journal of Gastroenterology is the official organ of the Sociedad Española de Patología Digestiva, the Sociedad Española de Endoscopia Digestiva and the Asociación Española de Ecografía Digestiva
Cookie policy Privacy Policy Legal Notice © Copyright 2023 y Creative Commons. The Spanish Journal of Gastroenterology